Clinical biomarkers in drug discovery and development - PubMed (original) (raw)

Review

doi: 10.1038/nrd1130.

Affiliations

• PMID: 12838269
• DOI: 10.1038/nrd1130

Review

Clinical biomarkers in drug discovery and development

Richard Frank et al. Nat Rev Drug Discov. 2003 Jul.

Abstract

Biomarkers enable the characterization of patient populations and quantitation of the extent to which new drugs reach intended targets, alter proposed pathophysiological mechanisms and achieve clinical outcomes. In genomics, the biomarker challenge is to identify unique molecular signatures in complex biological mixtures that can be unambiguously correlated to biological events in order to validate novel drug targets and predict drug response. Biomarkers can stratify patient populations or quantify drug benefit in primary prevention or disease-modification studies in poorly served areas such as neurodegeneration and cancer. Clinically useful biomarkers are required to inform regulatory and therapeutic decision making regarding candidate drugs and their indications in order to help bring new medicines to the right patients faster than they are today.

PubMed Disclaimer

Similar articles

• [Development of antituberculous drugs: current status and future prospects].
  Tomioka H, Namba K. Tomioka H, et al. Kekkaku. 2006 Dec;81(12):753-74. Kekkaku. 2006. PMID: 17240921 Review. Japanese.
• Biomarker assay translation from discovery to clinical studies in cancer drug development: quantification of emerging protein biomarkers.
  Lee JW, Figeys D, Vasilescu J. Lee JW, et al. Adv Cancer Res. 2007;96:269-98. doi: 10.1016/S0065-230X(06)96010-2. Adv Cancer Res. 2007. PMID: 17161683 Review.
• Complex disease-associated pharmacogenetics: drug efficacy, drug safety, and confirmation of a pathogenetic hypothesis (Alzheimer's disease).
  Roses AD, Saunders AM, Huang Y, Strum J, Weisgraber KH, Mahley RW. Roses AD, et al. Pharmacogenomics J. 2007 Feb;7(1):10-28. doi: 10.1038/sj.tpj.6500397. Epub 2006 Jun 13. Pharmacogenomics J. 2007. PMID: 16770341 Review.
• New science-based endpoints to accelerate oncology drug development.
  Kelloff GJ, Sigman CC. Kelloff GJ, et al. Eur J Cancer. 2005 Mar;41(4):491-501. doi: 10.1016/j.ejca.2004.12.006. Epub 2005 Jan 22. Eur J Cancer. 2005. PMID: 15737552 Review.
• The use of gene array technology and proteomics in the search of new targets of diseases for therapeutics.
  Ferrer-Alcón M, Arteta D, Guerrero MJ, Fernandez-Orth D, Simón L, Martinez A. Ferrer-Alcón M, et al. Toxicol Lett. 2009 Apr 10;186(1):45-51. doi: 10.1016/j.toxlet.2008.10.014. Epub 2008 Oct 28. Toxicol Lett. 2009. PMID: 19022361

Cited by

• Universal Biotin-PEG-Linked Gold Nanoparticle Probes for the Simultaneous Detection of Nucleic Acids and Proteins.
  Scott AW, Garimella V, Calabrese CM, Mirkin CA. Scott AW, et al. Bioconjug Chem. 2017 Jan 18;28(1):203-211. doi: 10.1021/acs.bioconjchem.6b00529. Epub 2016 Oct 14. Bioconjug Chem. 2017. PMID: 27740740 Free PMC article.
• DNA repair and personalized breast cancer therapy.
  Li SX, Sjolund A, Harris L, Sweasy JB. Li SX, et al. Environ Mol Mutagen. 2010 Oct-Dec;51(8-9):897-908. doi: 10.1002/em.20606. Environ Mol Mutagen. 2010. PMID: 20872853 Free PMC article. Review.
• From Maps to Multi-dimensional Network Mechanisms of Mental Disorders.
  Braun U, Schaefer A, Betzel RF, Tost H, Meyer-Lindenberg A, Bassett DS. Braun U, et al. Neuron. 2018 Jan 3;97(1):14-31. doi: 10.1016/j.neuron.2017.11.007. Neuron. 2018. PMID: 29301099 Free PMC article. Review.
• PRRT genomic signature in blood for prediction of 177Lu-octreotate efficacy.
  Bodei L, Kidd MS, Singh A, van der Zwan WA, Severi S, Drozdov IA, Cwikla J, Baum RP, Kwekkeboom DJ, Paganelli G, Krenning EP, Modlin IM. Bodei L, et al. Eur J Nucl Med Mol Imaging. 2018 Jul;45(7):1155-1169. doi: 10.1007/s00259-018-3967-6. Epub 2018 Feb 26. Eur J Nucl Med Mol Imaging. 2018. PMID: 29484451 Free PMC article.
• A knowledge-driven approach to extract disease-related biomarkers from the literature.
  Bravo À, Cases M, Queralt-Rosinach N, Sanz F, Furlong LI. Bravo À, et al. Biomed Res Int. 2014;2014:253128. doi: 10.1155/2014/253128. Epub 2014 Apr 16. Biomed Res Int. 2014. PMID: 24839601 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Nature Publishing Group

• Other Literature Sources

  • The Lens - Patent Citations Database